Nucleus Q1 PAT falls 32% YoY to ₹23.9 Cr — far worse ex a ₹9.8 Cr one-off; margins squeezed
PAT -32.19% YoY · revenue -3.35% · margins compressing
₹210.43 Cr
-3.35% YoY
₹23.87 Cr
-32.19% YoY
10.46%
-4.5pp YoY
₹9.07
Nucleus Software's Q1 FY27 (consolidated) was a weak print across every operating line. Revenue from operations of ₹210.4 Cr fell 3.3% YoY and 6.4% sequentially, and net profit of ₹23.9 Cr dropped 32% YoY — yet even that flatters the quarter, because it carries a ₹9.8 Cr exceptional GAIN (a gratuity and compensated-absences provision write-back) that the year-ago quarter did not have. Strip it out and underlying PAT is only ~₹16 Cr, roughly 54% below last year's ₹35.2 Cr. Profit before exceptional items and tax collapsed 58% YoY to ₹20.3 Cr — that, not the reported number, is the real read on the quarter.
Q1 FY-2027 vs prior quarters
The compression sits squarely on costs against a shrinking top line. Employee benefit expense rose 8% YoY to ₹157.2 Cr and operating/other expenses climbed 19% to ₹45.3 Cr while revenue actually fell, dragging net margin to ~11.4% from ~16.2% a year ago. Management had itself warned on the prior call that employee costs would stay elevated (team investments plus the new labour codes), and this quarter confirms that — but revenue did not grow to absorb it. The one-off gain is the mirror image of the ₹22 Cr labour-code provision Nucleus booked in FY26; a remuneration-structure change let it release part of that provision this quarter.
The stock went into the print at ₹737, down 1.8% over the past month of trading.
While the company does not provide specific revenue guidance, management highlighted a robust order book of INR 1,044.31 crore, expected to positively impact revenue over the next few quarters due to implementation cycles. Key strategic focus areas include strengthening co-lending, gold loans, and finance against secur
The company gives no formal revenue guidance, and the ₹1,044 Cr order book management pointed to last quarter as a forward lever has not yet reached the P&L — India revenue slipped to ₹118.1 Cr and only the Middle East and Far East geographies grew, while South East Asia stayed loss-making at −₹6.6 Cr segment PBT. There is no published sell-side consensus for this smallcap, so there is no street bar to grade against. Alongside the result, the board's ₹12.50/share FY26 final dividend was paid on 28 July, and the company disclosed a ₹47 lakh GST demand it intends to appeal. The standalone numbers tell the same story (PAT ₹22.95 Cr, EPS ₹8.72), with the standalone-vs-consolidated divergence small enough not to change the conclusion.
W1
Order-book conversion: the ₹1,044 Cr book management flagged as a revenue lever hasn't landed — revenue fell 3.3% YoY this quarter; watch for pickup in H2 FY27
W2
Employee cost trajectory (₹157.2 Cr, +8% YoY): management guides it stays elevated — watch whether it eases as labour-code impact anniversaries
W3
South East Asia segment loss (−₹6.6 Cr PBT), persistent for several quarters — watch for any turn to profit
Clean text PDF. Unit = ₹ Lakhs, converted to ₹ Cr. Consolidated is limited-review (unaudited); standalone is audited — hence period.audited=null. Key one-off: EXCEPTIONAL ITEM shown as (982) Lakh is a GAIN (₹9.82 Cr) — a write-back of gratuity (₹6.99 Cr) + compensated-absences (₹2.83 Cr) provisions after a remuneration-structure revision, reversing part of the ₹21.95 Cr labour-code charge booked in FY26. It lifts PBT from ₹20.28 Cr (pre-exceptional) to ₹30.10 Cr; year-ago quarter had NO exceptional item, so reported YoY understates the operating decline. No minority interest. Consolidated is primary basis.
Informational and educational content only. Not investment advice.